Results 21 to 30 of about 9,264,457 (358)

The change in the clinical presentation of Graves’ disease: a 30 years retrospective survey in an academic Brazilian tertiary center

open access: yesArchives of Endocrinology and Metabolism, 2020
Objective Graves’ disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has ...
Wanesa Pinto   +4 more
doaj   +1 more source

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives

open access: yesEndocrine Connections, 2022
Graves’ orbitopathy (GO) is a potentially sight-threatening and disfiguring, extrathyroidal manifestation of Graves’ disease. It often impairs patients’ qu ality of life, causing severe social and psychological sequelae.
Jakub Supronik   +3 more
doaj   +1 more source

Graves' ophthalmopathy: interdisciplinary approach

open access: yesКлиническая и экспериментальная тиреоидология, 2010
Graves' ophthalmopathy constitutes a major therapeutic challenge, so specialists of various disci-plines have to combine their forces. According to the last consensus of EUGOGO (European Group On Graves' Orbitopathy) the treatment of choice for Graves ...

doaj   +1 more source

Microchimerism and thyroid disorders: current knowledge and future prospects

open access: yesКлиническая и экспериментальная тиреоидология, 2015
This review will provide an overview of a novel phenomenon in medicine and endocrinology known as microchimerism (MC). MC is defined as the long-term presence of genetically distinct populations of cells in peripheral blood and tissues of individual ...
Ekaterina Arturovna Sabanova   +2 more
doaj   +1 more source

Case series of dermopathy in autoimmune thyroid disease [PDF]

open access: yesMedicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"
Graves' disease (GD) is an autoimmune disease that can affect other tissues in addition to the thyroid gland. The clinical manifestations are a result of the impact of TSH receptor antibodies.
Janić Tamara   +8 more
doaj   +1 more source

Advances in Graves' Disease [PDF]

open access: yesJournal of Thyroid Research, 2012
“From the very commencement the student should set out to witness the progress and effects of sickness and ought to persevere in the daily observation of disease during the whole period of his studies.” It was Dr. Robert J. Graves who used to pronounce this statement at the inauguration of his yearly university lectures in Dublin.
Lakdasa Premawardhana   +3 more
openaire   +3 more sources

Riedel Thyroiditis in a Patient with Graves Disease [PDF]

open access: yesEndocrinology and Metabolism, 2013
Riedel's thyroiditis is a rare form of infiltrative and inflammatory disease of the thyroid gland and can be associated with systemic fibrotic processes, Hashimoto thyroiditis and Graves disease.
Doo Young Lee   +4 more
doaj   +1 more source

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

open access: yesBMC Endocrine Disorders, 2018
Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning   +2 more
doaj   +1 more source

Graves's Disease [PDF]

open access: yesThe Boston Medical and Surgical Journal, 1880
n ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy